RhyGaze

Gene therapy. For sight.

Basel, Switzerland · $96.0M raised

Headquarters
Basel
Business Model
B2B
Total Funding
$96.0M
Last Round
$86.0M Series AJan 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

RhyGaze is a gene therapy company developing treatments to restore sight for people living with vision loss caused when cells in the eye lose the ability to convert light into an electrical signal. Its platform originated at the Institute of Molecular and Clinical Ophthalmology Basel, where researchers combined optogenetic proteins that engineer photosensitivity into mammalian cells with gene therapy tools that install that light-sensing machinery in target cells of the human eye. The team includes veterans of Luxturna, the first FDA-approved gene therapy for a genetic disease, and the company is based in Basel, Switzerland and Philadelphia, Pennsylvania.

Summary

RhyGaze is a Biotech company based in Basel, Switzerland. It has raised $96.0M in total across 2 rounds, most recently a $86.0M Series A round in Jan 2025. Investors include BioGeneration Ventures, GV and Novartis Venture Fund.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2025
$86.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RhyGaze on Indexed.vc
<a href="https://indexed.vc/companies/rhygaze"><img src="https://indexed.vc/api/badge/company/rhygaze" alt="RhyGaze on Indexed.vc" width="260" height="76" /></a>